Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of HIV and Risk of Multiple Sclerosis.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
The pill times 2: What every woman with multiple sclerosis should know.
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Expression and activation of human endogenous retroviruses of the W family in blood cells and astrocytes: implications for the pathogenesis of multiple sclerosis.
[Autophagy and its role in protective and damaging inflammatory response].
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Seeing optic neuritis through myopic eyes.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
Control of TH17 cells occurs in the small intestine.
Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia.
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Pages
« first
‹ previous
…
207
208
209
210
211
212
213
214
215
…
next ›
last »